本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Reata制药

172.36
+0.0000
成交量:- -
成交额:- -
市值:65.66亿
市盈率:-72.69
高:172.36
开:172.36
低:172.36
收:172.36
数据加载中...
2023/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/12

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/10

重要事件披露

8-K - Current report
2023/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/01

重要事件披露

8-K - Current report
2023/02/28

重要事件披露

8-K - Current report
2023/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/07

重要事件披露

8-K - Current report
2022/10/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans